PMID- 20814816 OWN - NLM STAT- MEDLINE DCOM- 20120913 LR - 20220321 IS - 1573-7217 (Electronic) IS - 0167-6806 (Linking) VI - 128 IP - 3 DP - 2011 Aug TI - Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer. PG - 647-55 LID - 10.1007/s10549-010-1150-2 [doi] AB - Increased expression and activation of focal adhesion kinase (FAK) was reported to be an unfavorable factor in various human cancers, including breast cancer. In order to study FAK gene status as a prognostic factor, we evaluated FAK gene copy number and FAK protein expression in invasive breast cancer. Tumors from 435 patients with invasive breast cancer were evaluated for FAK gene status using fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) based on tissue array method. Survival analyses were performed using the Kaplan-Meier method in 267 patients. 42 out of 362 evaluable cases (11.6%) showed high polysomy and 22 cases (6.1%) had gene amplification by FISH. 108 out of 393 evaluable cases (27.5%) showed FAK overexpression by IHC. FAK FISH positivity was significantly associated with higher histologic grade, higher T stage, negative estrogen receptor expression, negative progesterone receptor expression and triple-negative phenotype; FAK overexpression with higher histologic grade and triple-negative phenotype. FAK overexpression was noted in 57.8% (37 of 64) of FAK FISH+ cases. The concordance of FISH and IHC results for FAK gene was observed in 74.9% (271 of 362). Survival analyses revealed the patients with FAK FISH+ breast cancer had significantly shorter overall survival and relapse-free survival compared to those with FISH- breast cancer. In node-positive breast cancer patients who received postoperative systemic treatment, the patients with FAK FISH+ showed significantly shorter 5-year survival rates. Despite of high significant concordance between the results of FISH and IHC for FAK gene in invasive breast cancer, only FAK FISH positivity was an unfavorable prognostic factor. FAU - Yom, Cha Kyong AU - Yom CK AD - Department of Surgery, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. FAU - Noh, Dong-Young AU - Noh DY FAU - Kim, Woo Ho AU - Kim WH FAU - Kim, Hee Sung AU - Kim HS LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20100903 PL - Netherlands TA - Breast Cancer Res Treat JT - Breast cancer research and treatment JID - 8111104 RN - EC 2.7.10.2 (Focal Adhesion Protein-Tyrosine Kinases) SB - IM MH - Adult MH - Aged MH - Breast Neoplasms/diagnosis/*enzymology/*genetics/mortality/pathology MH - DNA Copy Number Variations/*genetics MH - Female MH - Focal Adhesion Protein-Tyrosine Kinases/*genetics/metabolism MH - Gene Expression/*genetics MH - Gene Expression Regulation, Neoplastic MH - Humans MH - Middle Aged MH - Neoplasm Staging MH - Prognosis MH - Survival Analysis EDAT- 2010/09/04 06:00 MHDA- 2012/09/14 06:00 CRDT- 2010/09/04 06:00 PHST- 2010/06/25 00:00 [received] PHST- 2010/08/23 00:00 [accepted] PHST- 2010/09/04 06:00 [entrez] PHST- 2010/09/04 06:00 [pubmed] PHST- 2012/09/14 06:00 [medline] AID - 10.1007/s10549-010-1150-2 [doi] PST - ppublish SO - Breast Cancer Res Treat. 2011 Aug;128(3):647-55. doi: 10.1007/s10549-010-1150-2. Epub 2010 Sep 3.